[Intermittent immunosuppressive therapy in idiopathic hemosiderosis of the lung (author's transl)].
D000477:Alkylating Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002675:Child, Preschool; D004035:Diet Therapy; D005021:Ethylamines / Q000627:therapeutic use; D006486:Hemosiderosis / Q000188:drug therapy* / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007223:Infant; D008171:Lung Diseases / Q000188:drug therapy* / Q000628:therapy; D008297:Male; D010078:Oxazines / Q000627:therapeutic use; D017976:Phosphorus Acids / Q000627:therapeutic use
D000477:Alkylating Agents; D005021:Ethylamines; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007166:Immunosuppressive Agents; D010078:Oxazines; D017976:Phosphorus Acids
Intermittierende immunsuppressive Behandlung bei idiopathischer Lungenhämosiderose.